Harrow, Inc. (HROW)
45.70
-1.36
(-2.89%)
USD |
NASDAQ |
Dec 15, 16:00
45.60
-0.10
(-0.22%)
After-Hours: 04:22
Harrow Research and Development Expense (TTM): 13.97M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Assertio Holdings, Inc. | 2.49M |
| Skye Bioscience, Inc. | 38.14M |
| Theravance Biopharma, Inc. | 37.97M |
| FibroGen, Inc. | 23.12M |
| NovaBay Pharmaceuticals, Inc. | -- |